The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Valliant John since 2022.
This trader's CIK number is 1813574.
At the time of last reporting, Valliant John was the Chief Executive Officer of Fusion Pharmaceuticals Inc.. (stock ticker symbol FUSN).
Also see all insider trading activities at Fusion Pharmaceuticals Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | FUSN | 0 | $0 | 213,787 | $1,599,711 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-04-26 | FUSN | Sale | 2,147 | 6.07 | 13,032 |
| 2022-04-27 | FUSN | Sale | 4,511 | 6.03 | 27,201 |
| 2022-04-25 | FUSN | Sale | 2,036 | 6.03 | 12,277 |
| 2022-04-20 | FUSN | Sale | 367 | 6.02 | 2,209 |
| 2022-04-21 | FUSN | Sale | 922 | 6.01 | 5,541 |
| 2022-04-12 | FUSN | Sale | 18,255 | 7.10 | 129,610 |
| 2022-04-11 | FUSN | Sale | 2,600 | 7.37 | 19,162 |
| 2022-04-13 | FUSN | Sale | 11,994 | 6.41 | 76,881 |
| 2022-04-07 | FUSN | Sale | 1,255 | 7.56 | 9,487 |
| 2022-04-06 | FUSN | Sale | 100 | 7.58 | 758 |
| 2022-04-08 | FUSN | Sale | 826 | 7.52 | 6,211 |
| 2022-04-05 | FUSN | Sale | 2,100 | 7.67 | 16,107 |
| 2022-04-04 | FUSN | Sale | 700 | 7.81 | 5,467 |
| 2022-04-01 | FUSN | Sale | 1,000 | 7.75 | 7,750 |
| 2022-03-30 | FUSN | Sale | 300 | 7.52 | 2,256 |
| 2022-03-28 | FUSN | Sale | 9,600 | 7.55 | 72,480 |
| 2022-03-29 | FUSN | Sale | 200 | 7.52 | 1,504 |
| 2022-03-25 | FUSN | Sale | 500 | 7.42 | 3,710 |
| 2022-03-21 | FUSN | Sale | 700 | 7.46 | 5,222 |
| 2022-03-22 | FUSN | Sale | 4,000 | 7.53 | 30,120 |
| 2022-03-23 | FUSN | Sale | 100 | 7.50 | 750 |
| 2022-03-17 | FUSN | Sale | 900 | 7.51 | 6,759 |
| 2022-03-18 | FUSN | Sale | 1,204 | 7.61 | 9,162 |
| 2022-03-21 | FUSN | Sale | 1,500 | 7.47 | 11,205 |
| 2022-03-14 | FUSN | Sale | 1,300 | 6.96 | 9,048 |
| 2022-03-15 | FUSN | Sale | 100 | 7.12 | 712 |
| 2022-03-16 | FUSN | Sale | 100 | 6.99 | 699 |
| 2022-03-11 | FUSN | Sale | 100 | 7.13 | 713 |
| 2022-03-10 | FUSN | Sale | 1,900 | 7.06 | 13,414 |
| 2022-03-09 | FUSN | Sale | 822 | 6.94 | 5,704 |
| 2022-03-04 | FUSN | Sale | 8,400 | 7.32 | 61,488 |
| 2022-03-07 | FUSN | Sale | 3,100 | 6.99 | 21,669 |
| 2022-03-08 | FUSN | Sale | 3,004 | 6.92 | 20,787 |
| 2022-03-01 | FUSN | Sale | 847 | 7.37 | 6,242 |
| 2022-03-03 | FUSN | Sale | 200 | 7.28 | 1,456 |
| 2022-03-02 | FUSN | Sale | 26,546 | 7.44 | 197,502 |
| 2022-02-24 | FUSN | Sale | 2,500 | 7.41 | 18,525 |
| 2022-02-25 | FUSN | Sale | 8,152 | 7.57 | 61,710 |
| 2022-02-28 | FUSN | Sale | 3,100 | 7.40 | 22,940 |
| 2022-02-23 | FUSN | Sale | 29,299 | 7.77 | 227,653 |
| 2022-02-22 | FUSN | Sale | 4,100 | 7.85 | 32,185 |
| 2022-02-18 | FUSN | Sale | 4,898 | 7.88 | 38,596 |
| 2022-02-17 | FUSN | Sale | 1,700 | 7.98 | 13,566 |
| 2022-02-15 | FUSN | Sale | 12,600 | 8.33 | 104,958 |
| 2022-02-16 | FUSN | Sale | 33,202 | 7.99 | 265,283 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Valliant John (Chief Executive Officer of Fusion Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.